Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Patient Information Leaflet last updated on the eMC: 07/10/2011
PIL Nebido 1000mg/4ml, solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 30/08/2011 and displayed until 07/10/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/02/2011 and displayed until 30/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 14/05/2009 and displayed until 22/02/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 08/07/2008 and displayed until 14/05/2009
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 29/08/2007 and displayed until 08/07/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 12/01/2005 and displayed until 29/08/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   testosterone undecanoate